Anyone good at Algebra ?

[brotherm1]

I'm trying to extrapolate what our weekly script and Symphony weekly sales revenues would look like if Afrezza was marketed to our entire US population of doctors and patients with diabetes. Mike said at this most recent investor conference their recent marketing study showed only 2% of our US population has heard of Aftezza. With our current weekly scripts of 380 and our weekly Symphony revenues of $318,000 with 2% of our population being aware of Afrezza, if 100% were aware, what could our weekly scripts and sales figures be? Of course the answer to this extrapolation would be assuming MNKD, or MNKD and a partner, or a company buying MNKD/Afrezza would have a sales infrastucture in place to market to 100% of doctors and PWD's.

[standup]

50 time 2% equals 100% so multiply everything by 50. I don't think the results mean much of anything but there you go.

[mytakeonit]

2% of the population may be aware of Afrezza ... but, they all aren't getting scripts or are diabetic. So, put that into your equation and tell me what you got.

Kazillion is the multiplier.

[itellthefuture777]

2 million patients 1 factory at max capacity is $6 billion a year based in cartridges not boxes.